Back to results
US 2025/0074861 A1Published application
Anticonvulsant Compounds
AssigneeOwen-Barry Pharmaceuticals Inc.
InventorsMichael POULTER (Deceased), Tony DURST
Life of this patent
Estimating the term…
Abstract
The present application relates to compounds and methods for reducing the severity of convulsant activity or epileptic seizures, or for the treatment of chronic or acute pain.
Claims6
1-32. (canceled)
A compound of formula (II):
- wherein,
- R1 and R2 are both CH3 or R1 is H and R2 is aryl, wherein aryl is:
- phenyl, which is optionally substituted with one or two of CH3, OH, OCH3, SO2CH3, SO2Ph, F, Cl, CF3, CN;
- 1- or 2-naphthyl;
- 2-, 3-, or 4-pyridyl, which is optionally substituted with one or two of CH3, OCH3, SO2CH3, SO2Ph, F, Cl, CF3, CN;
- 2- or 3-furyl, which is optionally substituted with one or two of CH3, OCH3, SO2CH3, SO2Ph, F, Cl, CF3, CN;
- or
- 2- or 3-thienyl, which is optionally substituted with one or two of CH3, OCH3, SO2CH3, SO2Ph, F, Cl, CF3, CN;
- R3 is:
- a straight C5 or C6 alkyl, a branched C3 to C6 alkyl, or CH(CH2)n, wherein n is an integer from 3 to 5;
- CH2SC6H5;
- C(O)CH(CN)CH3;
- CH═CHC(O)CH3, CH═CHC(O)C6H5, CH═CHC(O)—O—CH3, CH═CHC(O)—O—C2H5, CH═CHC(O)—O—CH(CH3)2, CH═CHC(O)—O—C4H9, or CH═CHC(O)—O—C6H5;
- CH(CN)CH3;
- CH═CHCN;
- or
- CH═CHSO2CH3, CH═CHSO2C6H5,
- with the proviso that when R1=R2=CH3:
- R3 is not a straight C5 or C6 alkyl, a branched C3 to C6 alkyl, CH(CH2)5, CH═CHC(O)CH3, CH═CHC(O)—O—CH3, or CH═CHC(O)—O—C2H5.
16 more elements
Dependencies are inferred from the claim text.